Equipment of this grade may seem like overkill, but Wirecutter’s Mark Smirniotis had several ... by confirming that the Maui Jim logo is etched, not just painted onto the lens.

Lee Joo-Sil, a veteran actress known for her role in Netflix‘s hit Squid Game and who appeared in such films like Train to Busan over the course of her six decade career, has died at her family ...

Lee Joo-Sil, who played Park Mal Soon, the mother of undercover detective Hwang Joon-Ho and ... [+] stepmother of Hwang In Ho in Netflix’s "Squid Games," died on Febraury 2. Lee Joo-Sil ...

By Etan Vlessing Canada Bureau Chief Korean actor Lee Joo Sil, who played the role of Park Mal Soon in the second season of Squid Game on Netflix, has died. She was 80. Among her last roles was in ...

making her mark in such films as zombie thriller “Train to Busan” in 2016 and “The Uncanny Counter” in 2020, according to People. This was not Joo-Sil’s first bout with cancer.

Lee Joo-sil, a longtime TV actress who had roles in ... and the stepmother of Hwang In Ho (Lee Byang Hun). This will mark her final on-screen role, coming off 22 episodes of “The Uncanny ...

SEOUL – South Korean actress Lee Joo-sil, who most recently appeared in the second season of global hit Squid Game (2021 to present), has died at the age of 80 on Feb 2, her agency 1230Culture said.

Lee was previously diagnosed with stage three breast cancer in her fifties and was given less than one year to live, but she received the all-clear from doctors 13 years later. Her funeral will be ...

Squid Game actor Lee Joo-sil has died three months after being diagnosed with stomach cancer. Lee played Hwang Joon-ho’s (Wi Ha-joon) mother in the second season of the dystopian Netflix drama.

The Sil Promesh® prosthesis presents two sides with diferent properties allowing its implantation in intra-peritoneal site. The visceral side is made of a Silicone membrane, designed for its non ...

South Korean newspaper The Chosun Ilbo reports that Lee passed away in her family home in Uijeongbu of stomach cancer, a diagnosis that she had received in November. Lee previously revealed that ...

Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings contribute to validating systemic administration as an ...